2019
Pathogen reduced plasma products: a clinical practice scientific review from the AABB. Transfusion. 2019;59(9):2974-2988.
PARP Inhibition Suppresses GR-MYCN-CDK5-RB1-E2F1 Signaling and Neuroendocrine Differentiation in Castration-Resistant Prostate Cancer. Clin Cancer Res. 2019;25(22):6839-6851.
Evaluation of peripheral blood mononuclear cell collection by leukapheresis. Transfusion. 2019;59(5):1765-1772.
- An Uncommon but Noteworthy Cause of Intrauterine Fetal Demise and Acute Necrotizing Funisitis. Fetal Pediatr Pathol. 2019;38(4):352-358.
Race and prostate imaging: implications for targeted biopsy and image-based prostate cancer interventions. BMJ Surg Interv Health Technol. 2019;1(1):e000010.
First Report of - and -Coharboring Species Isolated from a Pediatric Patient. mSphere. 2019;4(5).
A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204.
The Transcriptional Regulator Sin3A Contributes to the Oncogenic Potential of STAT3. Cancer Res. 2019;79(12):3076-3087.